Technology

Artificial intelligence may find a home in clinical trials and manufacturing in the coming years, but privacy, cyber security, and determining who owns the intellectual properties could pose challenges.

Webinar Date/Time: Wednesday, August 30, 2023 at 11am EDT

Recent events can provide digital therapeutics companies with clear lessons for the future.

In this interview, Arun Thachi, Director, Head of IT Marketing and Sales, Boehringer Ingelheim, discusses the AI journey in pharma.

The pluses for pharma are many—alongside experienced workers.

By using correct data and pertinent ML algorithms, customer engagement leaders can identify deep insights into customer behavior and make the right interventions to transform the customer experience.

Webinar Date/Time: Thu, May 18, 2023 11:00 AM EDT

Webinar Date/Time: Wednesday, May 24th, 2023 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST

Webinar Date/Time: Tuesday, March 14 2023, 9 am CT, 10 am ET, 3 pm GMT, 4 pm CET

Webinar Date/Time: Wed, Apr 12, 2023 1:00 PM EDT

Their integration across enterprise remains pivotal driver for success.

Biopharma insiders believe it’s time to invest in technology again.

Webinar Date/Time: Tuesday, February 28, 2023, 9 am CT, 10 am ET, 3 pm GMT, 4 pm CET

Webinar Date/Time: Tuesday, February 14, 2023, 9 am CT, 10 am ET, 3 pm GMT, 4 pm CET

AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.

Better technology is redefining pharmacovigilance as it expands beyond its traditional compliance focus to become a key business differentiator.

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST

Webinar Date/Time: Thu, Dec 8, 2022 2:00 PM EST

Webinar Date/Time: Tuesday, Dec 6, 2022, 11am PT | 2pm ET

Webinar Date/Time: Wednesday, November 30, 2022, 1 pm EDT

AI drives new signal-detection efforts in Alzheimer’s and ALS.

Jay Duker, MD, spoke with Pharm Exec about advancements in ocular drug delivery.

Life sciences companies a likely targets of these kinds of attacks.

Indu Navar, founder of Everything ALS, speaks with Pharm Exec about how she lost her husband to the disease and how she's trying to improve the way its diagnosed.